{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T11:22:25Z","timestamp":1790162545602,"version":"4.1.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.saa.2017.06.002","type":"journal-article","created":{"date-parts":[[2017,6,13]],"date-time":"2017-06-13T18:46:05Z","timestamp":1497379565000},"page":"59-65","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Quantitative analysis of anti-inflammatory drugs using FTIR-ATR spectrometry"],"prefix":"10.1016","volume":"186","author":[{"given":"Sonia T.","family":"Hassib","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghaneya S.","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmaa A.","family":"El-Zaher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3227-8683","authenticated-orcid":false,"given":"Marwa A.","family":"Fouad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enas A.","family":"Taha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.saa.2017.06.002_bb0005","series-title":"Handbook of Spectroscopy","author":"Gauglitz","year":"2014"},{"key":"10.1016\/j.saa.2017.06.002_bb0010","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.talanta.2013.06.020","article-title":"ATR-FTIR spectroscopy for the determination of Na4EDTA in detergent aqueous solutions","volume":"115","author":"Su\u00e1rez","year":"2013","journal-title":"Talanta"},{"key":"10.1016\/j.saa.2017.06.002_bb0015","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.saa.2013.06.032","article-title":"Application of attenuated total reflectance Fourier transform infrared spectroscopy for determination of cefixime in oral pharmaceutical formulations","volume":"115","author":"Kandhro","year":"2013","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.saa.2017.06.002_bb0020","series-title":"An Encyclopedia of Chemicals, Drugs and Biologicals","author":"The Merck Index","year":"2006"},{"issue":"2","key":"10.1016\/j.saa.2017.06.002_bb0025","first-page":"678","article-title":"Development and validation of stability indicating assay method of etodolac by using UV-visible spectrophotometer","volume":"2","author":"Palande","year":"2013","journal-title":"Int. J. Pharm. Chem. Sci."},{"issue":"10","key":"10.1016\/j.saa.2017.06.002_bb0030","first-page":"3309","article-title":"UV spectrophotometric determination of etodolac in tablet dosage form","volume":"4","author":"Bhandari","year":"2011","journal-title":"J. Pharm. Res."},{"issue":"5","key":"10.1016\/j.saa.2017.06.002_bb0035","first-page":"008","article-title":"Development and validation of stability indicating assay method for simultaneous determination of etodolac and thiocolchiside in bulk and tablet formulation by RP-HPLC method","volume":"5","author":"Garode","year":"2013","journal-title":"Int. J. Pharm. Res. Dev."},{"key":"10.1016\/j.saa.2017.06.002_bb0040","first-page":"201","article-title":"Etodolac in equine urine and serum: determination by high-performance liquid chromatography with ultraviolet detection, confirmation and metabolite identification by atmospheric pressure ionization mass spectrometry","volume":"23","author":"Mohammed","year":"1999","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.saa.2017.06.002_bb0045","series-title":"The Stationery Office on Behalf of the Medicines and Healthcare Products Regulatory Agency, London, UK","first-page":"725","author":"The British Pharmacopoeia","year":"2016"},{"key":"10.1016\/j.saa.2017.06.002_bb0050","first-page":"1","article-title":"Validation of a UV spectrometric method for the assay of tolfenamic acid in organic solvents","volume":"2015","author":"Ahmed","year":"2015","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.saa.2017.06.002_bb0055","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10637-009-9331-8","article-title":"Tolfenamic acid decreases c-met expression through Sp proteins degradation and inhibits lung cancer cells growth and tumor formation in orthotopic mice","volume":"29","author":"Colon","year":"2011","journal-title":"Investig. New Drugs"},{"issue":"2","key":"10.1016\/j.saa.2017.06.002_bb0060","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3233\/JAD-132726","article-title":"Reduction of \u03b2-amyloid deposition and attenuation of memory deficits by tolfenamic acid","volume":"43","author":"Subaiea","year":"2015","journal-title":"J. Alzheimers Dis."},{"issue":"9","key":"10.1016\/j.saa.2017.06.002_bb0065","first-page":"1533","article-title":"Quantitative determination of tolfenamic acid and its pharmaceutical formulation using FTIR and UV spectrometry","volume":"11","author":"Ahmed","year":"2013","journal-title":"Cent. Eur. J. Chem."},{"key":"10.1016\/j.saa.2017.06.002_bb0070","series-title":"Martindale: The Complete Drug Reference","first-page":"29","author":"Parfitt","year":"2009"},{"issue":"3","key":"10.1016\/j.saa.2017.06.002_bb0075","first-page":"499","article-title":"Comparison of bumadizone-, phenylbutazone- and oxyphenbutazone-plasma levels after a single oral dose of phenylbutazone and of bumadizone, respectively","volume":"31","author":"Spahn","year":"1981","journal-title":"Adv. Drug Res."},{"key":"10.1016\/j.saa.2017.06.002_bb0080","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.dit.2013.06.001","article-title":"Stability indicating spectrophotometric methods for determination of bumadizone in the presence of its alkaline degradation product","volume":"5","author":"Zaazaa","year":"2013","journal-title":"Drug Inv. Today"},{"issue":"4","key":"10.1016\/j.saa.2017.06.002_bb0085","first-page":"799","article-title":"Development and validation of stability indicating HPLC method for determination of diacerein and aceclofenac as bulk drug and in tablet dosage form","volume":"1","author":"Gandhi","year":"2011","journal-title":"Int. J. Res. Pharm. Chem."},{"key":"10.1016\/j.saa.2017.06.002_bb0090","doi-asserted-by":"crossref","first-page":"7582","DOI":"10.1016\/j.bmcl.2012.10.017","article-title":"Synthesis and pharmacokinetic profile of rhein- boswellic acid conjugate","volume":"22","author":"Suneela","year":"2012","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"2","key":"10.1016\/j.saa.2017.06.002_bb0095","first-page":"10","article-title":"Synthesis of 4, 5-dihydroxy-9, 10-dioxoanthracene-2-benzyl carboxylate ester from rhein","volume":"1","author":"Gavit","year":"2012","journal-title":"J. Pharmacogn. Phytother."},{"issue":"8","key":"10.1016\/j.saa.2017.06.002_bb0100","first-page":"2927","article-title":"Quantitative determination of etodolac by UV spectrophtometric method in bulk drug and commercial formulations","volume":"4","author":"Insuyu","year":"2013","journal-title":"IJPSR"},{"issue":"4","key":"10.1016\/j.saa.2017.06.002_bb0105","first-page":"202","article-title":"Spectrophotometric determination of diacerein in bulk and pharmaceutical formulation","volume":"1","author":"Nyola","year":"2010","journal-title":"Int J Pharm. Bio. Sci"}],"container-title":["Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386142517304626?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386142517304626?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,11]],"date-time":"2020-03-11T11:08:18Z","timestamp":1583924898000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386142517304626"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":21,"alternative-id":["S1386142517304626"],"URL":"https:\/\/doi.org\/10.1016\/j.saa.2017.06.002","relation":{},"ISSN":["1386-1425"],"issn-type":[{"value":"1386-1425","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantitative analysis of anti-inflammatory drugs using FTIR-ATR spectrometry","name":"articletitle","label":"Article Title"},{"value":"Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.saa.2017.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}